Correlation Between Talis Biomedical and ReShape Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talis Biomedical Corp and ReShape Lifesciences, you can compare the effects of market volatilities on Talis Biomedical and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and ReShape Lifesciences.

Diversification Opportunities for Talis Biomedical and ReShape Lifesciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Talis and ReShape is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between Talis Biomedical and ReShape Lifesciences

If you would invest (100.00) in Talis Biomedical Corp on January 15, 2025 and sell it today you would earn a total of  100.00  from holding Talis Biomedical Corp or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Talis Biomedical Corp  vs.  ReShape Lifesciences

 Performance 
       Timeline  
Talis Biomedical Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, Talis Biomedical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
ReShape Lifesciences 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ReShape Lifesciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, ReShape Lifesciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

Talis Biomedical and ReShape Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Talis Biomedical and ReShape Lifesciences

The main advantage of trading using opposite Talis Biomedical and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.
The idea behind Talis Biomedical Corp and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites